LaVoieHealthScience Promotes Sharon Correia to Senior Vice President, Integrated Communications

Boston, MA – September 5, 2018 – LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced the promotion of Sharon Correia to Senior Vice President, Integrated Communications.

Ms. Correia joined LHS in 2016 as Vice President, Integrated Communications from Navidea Biopharmaceuticals, where she was Sr. Director of Corporate Communications. An industry veteran with more than two decades of health and science communications experience spanning agency, publicly-traded and private companies, Sharon designs and executes programs that resonate from development phase through commercialization. Sharon has demonstrated alignment with LHS’s core values and a fast-moving, collaborative culture focused on problem solving.

“I am delighted to celebrate Sharon’s success at LHS and the engagement and experience that she brings to our people, clients and community. In her new role, Sharon continues to report to me and works with the senior leadership team on client strategy, execution, team building and high-level programming,” stated Donna L. LaVoie, President & CEO of LaVoieHealthScience.

Sharon brings industry-tested integrated communications experience spanning public and medical communications, investor communications and professional advocacy relations. She’s led communications teams for multiple new drug applications in the US and EU, global product launches as well as several sNDA’s, IPOs and key data dissemination at medical meetings.

“I am truly excited to continue to contribute my expertise to the well-regarded group of specialized thinkers at LHS who are solving client problems and helping them advance health and science innovation,” said Correia. “Each and every LHS client provides our team with unique and dramatic perspectives on how creative story-telling creates competitive advantage.”

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides public relations, investor relations and marketing and digital communications to build recognition and increase sales and value for health science innovations. The agency has received over 30 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients and was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies. LaVoieHealthScience represents leaders such as, Emmaus Life Sciences, Landos Biopharma, LEO Science & Tech Hub, Life Sciences Corridor, NewLink Genetics, Newron Pharmaceuticals, Origenis GmbH, PathMaker Neurosystems, Scioto Biosciences, Symbiotix Biotherapies, Triumvira Immunologics, XenoTherapeutics, Xontogeny LLC, and other emerging health and science companies.


Media Contact:
Katie Gallagher
Account Manager, PR and Marketing
617-374-8800 x109